LONGEVA.

MK-677: adverse events and evidence limits

A one-year oral MK-677 analysis in healthy adults aged 60–81 described increased appetite, mild transient leg edema and muscle pain. Fasting glucose rose and insulin sensitivity declined. [1]

These findings concern the studied tablets and cohort. [1]

What the studies reported

EffectModel or participantsHow often or as describedSource
Increased appetiteHealthy adults aged 60–81, oral MK-677, one-year analysisDescribed; no percentage given in the abstract[1]
Mild transient leg edemaThe same participantsDescribed as mild and transient; no frequency given[1]
Muscle painThe same participantsDescribed; no frequency given[1]
Fasting glucose rise and reduced insulin sensitivityThe same participantsObserved; metabolic measurements, no percentage given[1]

References

  1. Ralf Nass et al. (2008). Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial https://doi.org/10.7326/0003-4819-149-9-200811040-00003.